{"id":"NCT00891735","sponsor":"Genentech, Inc.","briefTitle":"A Study of Ranibizumab Administered Monthly or on an As-needed Basis in Patients With Subfoveal Neovascular Age-related Macular Degeneration (HARBOR)","officialTitle":"A Phase III, Double-masked, Multicenter, Randomized, Active Treatment-controlled Study of the Efficacy and Safety of 0.5 mg and 2.0 mg Ranibizumab Administered Monthly or on an As-needed Basis (PRN) in Patients With Subfoveal Neovascular Age-related Macular Degeneration","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-07","primaryCompletion":"2011-08","completion":"2012-08","firstPosted":"2009-05-01","resultsPosted":"2013-01-18","lastUpdate":"2013-01-18"},"enrollment":1097,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Age-related Macular Degeneration"],"interventions":[{"type":"DRUG","name":"Ranibizumab","otherNames":["Lucentis"]}],"arms":[{"label":"Ranibizumab 0.5 mg monthly","type":"EXPERIMENTAL"},{"label":"Ranibizumab 2.0 mg monthly","type":"EXPERIMENTAL"},{"label":"Ranibizumab 0.5 mg as-needed (pro re nata [PRN])","type":"EXPERIMENTAL"},{"label":"Ranibizumab 2.0 mg as-needed (pro re nata [PRN])","type":"EXPERIMENTAL"}],"summary":"This is a Phase III, multicenter, randomized, double-masked, dose-comparison study of the efficacy and safety of ranibizumab injection administered intravitreally to patients with choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). Results are presented for the first 12 months of the study.","primaryOutcome":{"measure":"Change From Baseline in Best Corrected Visual Acuity (BCVA) at Month 12","timeFrame":"Baseline to Month 12","effectByArm":[{"arm":"Ranibizumab 0.5 mg Monthly","deltaMin":10.1,"sd":13.3},{"arm":"Ranibizumab 2.0 mg Monthly","deltaMin":9.2,"sd":14.6},{"arm":"Ranibizumab 0.5 mg As-needed (Pro re Nata [PRN])","deltaMin":8.2,"sd":13.3},{"arm":"Ranibizumab 2.0 mg As-needed (Pro re Nata [PRN])","deltaMin":8.6,"sd":13.8}],"pValues":[]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":18},"locations":{"siteCount":99,"countries":["United States"]},"refs":{"pmids":["39287532","37079518","36729084","36372347","35654363","35342822","35239009","34934034","34289338","33331859","32402555","32387055","32374423","32353536","31735634","31416763","31281056","31021381","27566855","26541435","23352196"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":66,"n":274},"commonTop":["Conjunctival haemorrhage","Vitreous detachment","Eye pain","Vitreous detachment","Hypertension"]}}